Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and ER-Negative PR-Negative HER2-Negative Breast Cancer

gadolinium dtpa has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, M; Li, MJ; Liu, WL; Luo, XJ; Lv, RC; Ming, ZH; Song, L; Zhang, GJ; Zhang, LX; Zhang, YQ; Zhu, YY1
Cha, JH; Chae, EY; Choi, WJ; Eom, HJ; Kim, HH; Shin, HJ1
Kim, EK; Kim, MJ; Kim, SI; Moon, HJ; Park, BW; Park, S1
Barnes, SL; Loveless, ME; Sorace, AG; Whisenant, JG; Yankeelov, TE1
Baek, SH; Cha, JH; Gong, G; Kim, HH; Ku, YJ; Lee, HJ; Shin, HJ1

Other Studies

5 other study(ies) available for gadolinium dtpa and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Novel Dual-Mode NIR-II/MRI Nanoprobe Targeting PD-L1 Accurately Evaluates the Efficacy of Immunotherapy for Triple-Negative Breast Cancer.
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Animals; B7-H1 Antigen; Gadolinium DTPA; Humans; Immunotherapy; Indocyanine Green; Magnetic Resonance Imaging; Mice; Triple Negative Breast Neoplasms

2023
Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
    AJR. American journal of roentgenology, 2017, Volume: 208, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Contrast Media; Drug Monitoring; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Observer Variation; Prognosis; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden

2017
Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
    Acta radiologica (Stockholm, Sweden : 1987), 2015, Volume: 56, Issue:9

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Contrast Media; Cyclophosphamide; Docetaxel; Female; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Predictive Value of Tests; Retrospective Studies; Taxoids; Triple Negative Breast Neoplasms

2015
Correlation of tumor characteristics derived from DCE-MRI and DW-MRI with histology in murine models of breast cancer.
    NMR in biomedicine, 2015, Volume: 28, Issue:10

    Topics: Albumin-Bound Paclitaxel; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Contrast Media; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Heterografts; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy; Receptor, ErbB-2; Trastuzumab; Triple Negative Breast Neoplasms

2015
Correlation Between MRI and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer.
    AJR. American journal of roentgenology, 2016, Volume: 207, Issue:5

    Topics: Adult; Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Gadolinium DTPA; Humans; Lymphocytes, Tumor-Infiltrating; Meglumine; Middle Aged; Organometallic Compounds; Prognosis; Retrospective Studies; Triple Negative Breast Neoplasms

2016